Seer Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Seer Inc inventory turnover ratio, the Seer Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.96 in the second quarter 2026, yet the ratio remained below the average, as SEER's market remain challenging.Average inventory processing period, for the Seer Inc in Jun 30 2026 quarter, has decreased to 380 days, compare to 410 days, in the Mar 31 2026 quarter.

Within Healthcare sector 320 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1846, from total ranking in the first quarter 2026 at 1975.

SEER Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Seer Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SEER Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	2.01 %	14.27 %	4.83 %	17.17 %	-0.91 %
Y / Y Cost of Sales Growth	59.6 %	-50 %	0 %	0 %	0 %
Inventory Turnover Ratio (TTM)	0.96	0.89	1.05	1.06	1.11
SEER's Total Ranking	# 1846	# 1975	# 1882	# 1872	# 1892
Average inventory processing period	380	411	348	344	330
Seq. Inventory Growth	-5.15 %	3.64 %	-4.07 %	8.17 %	6.25 %
Seq. Cost of Sales Growth	59.6 %	-66.67 %	50 %	100 %	-50 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 20
Healthcare Sector	# 321
Overall Market	# 1846

Inventory Turnover Ratio Statistics
High	Average	Low
374.81	19.45	0.89
(Sep 30 2014)		(Mar 31 2026)

SEER Company Profile >> Back to SEER Efficiency Comparisons >> Compare SEER Inventory Turnover Ratio to its Competitors

Financial Statements
Seer Inc 's Inventories	$ 8 Millions	Visit SEER's Balance sheet
Seer Inc 's Cost of Revenues TTM	$ 8 Millions	Visit SEER's Income Statement
What are SEER's Sales?		Visit SEER's Sales by Segment

Other Inventory Turnover Ratios
Seer Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SEER's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SEER's Competitors
Inventory Turnover Ratio for SEER's Suppliers
Inventory Turnover Ratio for SEER's Customers

You may also want to know
SEER's Sales Growth Rates	SEER's Pe Price to earnings ratio	SEER's Receivables Turnover Ratio	SEER's Stock Quote
SEER's Net Income Growth Rates	SEER's Ps Price to Sales ratio	SEER's Sales per Employee	SEER's Asset Turnover Ratio
SEER's Net Margin	SEER's Pb Price to Book ratio	SEER's Financial Strength Ratios	SEER's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Pro dex Inc	2.43	$ 53.213 Millions	$ 22 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Journey Medical Corp	2.42	$ 23.556 Millions	$ 10 Millions
Aquestive Therapeutics Inc	2.42	$ 17.828 Millions	$ 7 Millions
Viatris Inc	2.41	$ 9,604.200 Millions	$ 3,993 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
Tela Bio Inc	2.30	$ 26.348 Millions	$ 11 Millions
Sanara Medtech Inc	2.29	$ 7.981 Millions	$ 3 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions
Medtronic Plc	2.21	$ 13,136.000 Millions	$ 5,950 Millions
Embecta Corp	2.19	$ 418.400 Millions	$ 191 Millions
Avita Medical Inc	2.18	$ 13.950 Millions	$ 6 Millions
Johnson and Johnson	2.17	$ 31,428.000 Millions	$ 14,516 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	2.15	$ 14.508 Millions	$ 7 Millions
Anika Therapeutics Inc	2.14	$ 46.366 Millions	$ 22 Millions
Amphastar Pharmaceuticals Inc	2.14	$ 381.911 Millions	$ 178 Millions
Dariohealth Corp	2.10	$ 8.985 Millions	$ 4 Millions
Bio techne Corp	2.10	$ 414.798 Millions	$ 197 Millions

Date modified: 2026-09-05T00:14:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.